About
Alamar Biosciences, Inc.
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.
It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics.
Alamar Biosciences, Inc. Overview
Ticker, listing venue and issuer profile
Offer & Key Dates
Pricing terms and IPO milestones
Change from offer price to today
Live Market Snapshot
Real-time price; headline % change is vs first trade (listing price)
USD · NASDAQ:NASDAQ:ALMR
Valuation & Multiples
Key valuation ratios and metrics
Financial Health
Balance sheet strength and liquidity
Analyst Estimates
Street consensus and price targets
Risk Metrics
Volatility versus the market
Earnings Calendar
Upcoming and recent earnings
Financial Highlights
Historical financial performance
Historical Data
Market history and supplemental quote data
| Date | Open | High | Low | Close | Adj. Close | Change | Volume |
|---|---|---|---|---|---|---|---|
| 2026-05-13 | $22.99 | $24.88 | $22.75 | $23.01 | $23.01 | +0.02 | 222,300 |
| 2026-05-12 | $23.92 | $24.97 | $22.76 | $22.97 | $22.97 | -0.95 | 158,700 |
| 2026-05-11 | $23.90 | $25.00 | $23.59 | $23.88 | $23.88 | -0.02 | 139,100 |
| 2026-05-08 | $23.12 | $25.21 | $23.12 | $23.96 | $23.96 | +0.84 | 304,600 |
| 2026-05-07 | $23.85 | $24.12 | $22.75 | $23.66 | $23.66 | -0.19 | 270,100 |
| 2026-05-06 | $24.10 | $24.83 | $23.63 | $23.84 | $23.84 | -0.26 | 289,600 |
| 2026-05-05 | $23.67 | $24.42 | $23.13 | $23.90 | $23.90 | +0.23 | 122,700 |
| 2026-05-04 | $25.66 | $26.57 | $23.58 | $23.76 | $23.76 | -1.90 | 181,900 |
| 2026-05-01 | $25.12 | $26.87 | $25.04 | $25.81 | $25.81 | +0.69 | 380,900 |
| 2026-04-30 | $24.56 | $25.71 | $24.50 | $25.04 | $25.04 | +0.48 | 226,600 |
| 2026-04-29 | $26.37 | $26.68 | $23.71 | $24.48 | $24.48 | -1.89 | 222,000 |
| 2026-04-28 | $26.69 | $27.20 | $25.59 | $26.11 | $26.11 | -0.58 | 227,400 |
| 2026-04-27 | $24.67 | $27.00 | $24.28 | $26.69 | $26.69 | +2.02 | 429,500 |
| 2026-04-24 | $24.45 | $24.98 | $24.28 | $24.84 | $24.84 | +0.39 | 707,700 |
| 2026-04-23 | $24.55 | $24.55 | $23.05 | $24.27 | $24.27 | -0.28 | 187,000 |
| 2026-04-22 | $23.24 | $25.03 | $22.75 | $24.27 | $24.27 | +1.03 | 342,400 |
| 2026-04-21 | $21.75 | $23.68 | $21.75 | $23.23 | $23.23 | +1.48 | 457,300 |
| 2026-04-20 | $22.34 | $24.50 | $21.80 | $22.00 | $22.00 | -0.34 | 1,069,500 |
| 2026-04-17 | $22.60 | $24.50 | $21.50 | $22.00 | $22.00 | -0.60 | 4,895,500 |
SEC Filings
Official documents from SEC EDGAR
| Form | Filing Date | Document |
|---|---|---|
| 10-Q | May 8, 2026 | Quarterly Report |
| 8-K | May 8, 2026 | Current Report |
| SCHEDULE 13D | Apr 23, 2026 | Filing |
| SCHEDULE 13D | Apr 23, 2026 | Filing |
| EFFECT | Apr 20, 2026 | Notice of Effectiveness |
| S-8 | Apr 20, 2026 | Securities to be offered to employees in employee benefit plans |
| 8-K | Apr 20, 2026 | Current Report |
| POS AM | Apr 20, 2026 | Post-Effective amendments for registration statement |
| 424B4 | Apr 17, 2026 | Prospectus |
| EFFECT | Apr 16, 2026 | Notice of Effectiveness |
Company Info
Contact and headquarters details
Leadership
Key executives and officers
Yuling Luo, Ph.D.
Founder, Chief Executive Officer and Chairman
Timothy “Tod” White
President
Justin McAnear
Chief Financial Officer
Shiping “Steve” Chen, Ph.D.
Founder, Chief Operating Officer and Director
Rebecca Chambers
Director
Nicholas Naclerio, Ph.D.
Director
Ian W. Ratcliffe
Director
Frank R. Witney, Ph.D.
Director
